1Glaxo Department of Ophthalmic Epidemiology, Institute of Ophthalmology, London, United Kingdom.
National screening programs for eye disease are not currently recommended due to issues with test validity and resource allocation. Improved screening tests are under investigation, but current focus should be on enhancing existing case-finding methods.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: